AXGN — Axogen, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 805928 ·
Last close
$55.37
Market Cap
$3.31B
52W High
$59.72
52W Low
$23.00
ADV30
1,850,419
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 69,731,000 | 50,674,000 | -2,156,000 | -1,516,000 | 304,863,000 | 94,572,000 | 48,606,000 |
| Mar 2026 | 61,457,000 | 46,189,000 | -2,832,000 | -19,584,000 | 289,488,000 | 82,654,000 | 44,680,000 |
| Dec 2025 | 59,904,000 | 44,409,000 | -9,772,000 | -13,156,000 | 221,687,000 | 35,548,000 | 92,840,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$15,047,000
Investing CF
$-15,173,000
Financing CF
$70,662,000
CapEx
$-8,537,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.65
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-328,063,000
Inventory
$47,313,000
Receivables
$34,126,000
ST Investments
$16,840,000
EBIT TTM
$-29,378,000
Pretax Income TTM
$-33,548,000
Interest Exp TTM
$4,170,000
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$266,926,000
EBITDA
$-6,962,000
Free Cash Flow
$29,814,124
Enterprise Value
$2,620,306,432
Total Cash
$348,068,000
Total Debt
$19,469,000
Shares Out
59,730,715
Trailing EPS
$-0.63
Book Value
$8.31
ROE
-10.3%
ROA
-2.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 225,208,000 | -7,849,000 | -15,703,000 | 221,687,000 | 92,840,000 | 128,847,000 | 812,000 |
| Dec 2024 | 187,338,000 | -3,287,000 | -9,964,000 | 203,728,000 | 99,821,000 | 103,907,000 | 4,535,000 |
| Dec 2023 | 159,012,000 | -21,462,000 | -21,716,000 | 196,827,000 | 101,162,000 | 95,665,000 | -5,716,000 |
| Dec 2022 | 138,584,000 | -29,707,000 | -28,948,000 | 195,387,000 | 94,388,000 | 100,999,000 | -16,066,000 |
TTM Snapshot
Revenues TTM
$251,174,000
NetIncome TTM
$-33,548,000
OpCashFlow TTM
—
Assets (Latest)
$304,863,000
Forward EPS
$0.71
Max Pain — expiry 2027-04-16
max pain strike: $40.00 · spot: $56.95 · call oi: 1,846 · put oi: 78
Expected Move to 2027-04-16:
±$17.35
(30.47%) —
implied range
$39.60 –
$74.30
· ATM straddle on $55.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PLSE | PULSE BIOSCIENCES, INC. | $3.30B | $44.84 | — |
| TMDX | TransMedics Group, Inc. | $3.26B | $93.91 | — |
| IRTC | iRhythm Holdings, Inc. | $2.98B | $89.67 | — |
| NVST | Envista Holdings Corp | $3.80B | $23.70 | — |
| ATRC | AtriCure, Inc. | $2.80B | $55.02 | — |
News headlines (Yahoo Finance, 1h cache)
AxoGen: 3 Key Takeaways for Long-Term Investors
2026-11-16 22:20 · Yahoo
AxoGen (AXGN) is a Great Momentum Stock: Should You Buy?
2026-11-12 16:00 · Yahoo
Axogen (AXGN) Stock Could Be 22% Overvalued On Cash Flow Expectations
2026-11-12 07:16 · Yahoo
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
2026-11-03 12:00 · Yahoo
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?
2026-11-02 15:40 · Yahoo
Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year?
2026-10-29 12:40 · Yahoo
Does Axogen (AXGN) Have More Upside Or Is It Fully Priced?
2026-10-28 23:15 · Yahoo
AxoGen Q3 Earnings Call Highlights
2026-10-28 22:04 · Yahoo
AxoGen, Inc. Q3 2026 Earnings Call Summary
2026-10-28 20:52 · Yahoo
AxoGen: Q3 Earnings Snapshot
2026-10-28 18:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.